# Sufentanil in Patients With Lower Extremity Fracture Surgery Myocardial Damage Function Study

> **NCT06808841** · NA · NOT_YET_RECRUITING · sponsor: **Second Hospital of Shanxi Medical University** · enrollment: 160 (estimated)

## Conditions studied

- Myocardial Injury

## Interventions

- **DRUG:** Sufentanil injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06808841
- **Lead sponsor:** Second Hospital of Shanxi Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-05
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-05-10
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06808841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06808841, "Sufentanil in Patients With Lower Extremity Fracture Surgery Myocardial Damage Function Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06808841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*